Wednesday, February 10, 2010, 2:56am EST - Canadian Markets open in 6 hours and 34 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Illumina Inc. (ILMN)

 On Feb 9: 35.83 USD  Up 0.16 (0.45%)  
MORE ON ILMN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Illumina, Inc. (NasdaqNM:ILMN) Delayed quote dataEdit
After Hours: 35.67 Down 0.16 (0.45%) as of 8:01pm EST on 02/09/10
Last Trade: 35.83 USD
Trade Time: Feb 9
Change: Up 0.16 (0.45%)
Prev Close: 35.67
Open: 35.50
Bid: N/A
Ask: 39.78 x 100
1y Target Est: 43.23
Day's Range: 35.34 - 36.00
52wk Range: 25.59 - 44.07
Volume: 1,638,909
Avg Vol (3m): 3,245,320
Market Cap: 4.40B
P/E (ttm): 67.99
EPS (ttm): 0.53
Div & Yield: N/A (N/A%)
Illumina Inc. (ILMN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add ILMN to Portfolio   Download Data

HEADLINES
• No Affymetrix Performance from Illumina; Stock Sinks as Year Forecast Misses
at Barrons.com (Tue 8:20pm)
• Biotech Deal-Making Crosses Borders as Capital Markets Slide
at Seeking Alpha (Tue 4:32am)
• Neurocrine names CEO of Receptos to its board
AP (Mon, Feb 8)
• An Earnings Surprise of an Unusual Kind
at Motley Fool (Mon, Feb 8)
• New Star Analyst Rankings for Illumina, Inc.
StarMine (Sat, Feb 6)
• Genetics Researcher Ready For Prime Time
Investor's Business Daily (Fri, Feb 5)
• Biotech Stocks: Drug stocks fall; Alkermes rallies on upgrade
at MarketWatch (Fri, Feb 5)
• Holy Cow
at Forbes.com (Fri, Feb 5)
• Biotech Stocks: Drug stocks slip; Alkermes rallies on upgrade
at MarketWatch (Fri, Feb 5)
• US STOCKS-Futures off as Europe worries linger ahead of data
at Reuters (Fri, Feb 5)
• Futures point to lower open on Wall Street
at Reuters (Fri, Feb 5)
• Illumina, Inc Q4 2009 Earnings Call Transcript
at Seeking Alpha (Thu, Feb 4)
More Headlines for ILMN...
ANALYST
EPS Est (next year) (Dec-10) : 1.00
EPS Est (in 2 years) (Dec-11) : 1.31
Avg Rec (current)*: 2.1
PEG Ratio: 1.49
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Illumina, Inc. engages in the development, manufacture, and marketing of integrated systems for the analysis of genetic variation and biological function.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices